Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verve Therapeutics, Inc. | 2,008,809 | 2,008,809 | 0 | $28.00M | $26.68M | 33.23% | -$1.33M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $23.55M | $22.77M | 28.37% | -$773.9K |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $7.35M | $9.51M | 11.84% | +$2.15M |
| Denali Therapeutics Inc.(DNLI) | 381,249 | 381,249 | 0 | $8.18M | $7.82M | 9.75% | -$358.4K |
| Q32 Bio Inc.(QTTB) | 0 | 320,482 | +320,482 | $0 | $5.46M | 6.80% | +$5.46M |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 0 | 1,444,296 | +1,444,296 | $0 | $4.43M | 5.52% | +$4.43M |
| Singular Genomics Systems, Inc. | 3,798,926 | 3,798,926 | 0 | $1.75M | $1.95M | 2.43% | +$205.5K |
| Unity Biotechnology, Inc. | 1,004,817 | 1,004,817 | 0 | $1.94M | $1.65M | 2.05% | -$291.4K |
| Revolution Medicines, Inc.(RVMD) | 3,233,490 | 0 | -3,233,490 | $92.74M | $0 | — | -$92.74M |